Product Code: ETC6188442 | Publication Date: Sep 2024 | Updated Date: May 2025 | Product Type: Market Research Report | |
Publisher: 6Wresearch | Author: Vasudha | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
This niche medical devices market involves tools and equipment used primarily in dental care and cardiovascular treatments to modify or remove plaque. In Australia, the demand for plaque modification devices is driven by increasing awareness of oral health and cardiovascular disease prevention. Innovations focus on minimally invasive procedures and devices that improve treatment efficacy and patient comfort.
The plaque modification devices market in Australia is progressing due to growing incidences of peripheral artery disease and cardiovascular conditions requiring advanced endovascular treatments. Technological advancements such as atherectomy devices, laser-based plaque removal, and drug-coated balloons are improving procedural efficacy and patient outcomes. Increasing awareness among healthcare professionals and availability of reimbursement schemes are enhancing adoption rates. Research focused on minimally invasive techniques is shaping market dynamics.
The Australia Plaque Modification Devices Market is challenged by regulatory approval processes that require extensive clinical data. High costs of devices and limited reimbursement options affect market penetration. Furthermore, awareness among healthcare providers and patients about the benefits of these devices remains low, hindering adoption.
In the medical device sector, plaque modification devices used in cardiovascular treatments are a niche yet growing market. Investors can focus on the development and clinical trials of innovative devices for plaque removal or stabilization. Collaboration with healthcare providers and regulatory bodies is key to successful market entry and expansion.
The medical devices industry, including plaque modification devices, is tightly regulated by the Therapeutic Goods Administration (TGA). Government policies require rigorous clinical trials and post-market surveillance to ensure safety and effectiveness. Reimbursement frameworks under Medicare and private health insurance schemes influence device adoption and market growth.
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Australia Plaque Modification Devices Market Overview |
3.1 Australia Country Macro Economic Indicators |
3.2 Australia Plaque Modification Devices Market Revenues & Volume, 2021 & 2031F |
3.3 Australia Plaque Modification Devices Market - Industry Life Cycle |
3.4 Australia Plaque Modification Devices Market - Porter's Five Forces |
3.5 Australia Plaque Modification Devices Market Revenues & Volume Share, By Product Type, 2021 & 2031F |
3.6 Australia Plaque Modification Devices Market Revenues & Volume Share, By Application, 2021 & 2031F |
3.7 Australia Plaque Modification Devices Market Revenues & Volume Share, By End User, 2021 & 2031F |
4 Australia Plaque Modification Devices Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.3 Market Restraints |
5 Australia Plaque Modification Devices Market Trends |
6 Australia Plaque Modification Devices Market, By Types |
6.1 Australia Plaque Modification Devices Market, By Product Type |
6.1.1 Overview and Analysis |
6.1.2 Australia Plaque Modification Devices Market Revenues & Volume, By Product Type, 2021- 2031F |
6.1.3 Australia Plaque Modification Devices Market Revenues & Volume, By Atherectomy Devices, 2021- 2031F |
6.1.4 Australia Plaque Modification Devices Market Revenues & Volume, By Thrombectomy Devices, 2021- 2031F |
6.1.5 Australia Plaque Modification Devices Market Revenues & Volume, By Chronic Total Occlusion (CTO) Devices, 2021- 2031F |
6.1.6 Australia Plaque Modification Devices Market Revenues & Volume, By Embolic Protection Devices (EPD), 2021- 2031F |
6.2 Australia Plaque Modification Devices Market, By Application |
6.2.1 Overview and Analysis |
6.2.2 Australia Plaque Modification Devices Market Revenues & Volume, By Coronary Artery Disease, 2021- 2031F |
6.2.3 Australia Plaque Modification Devices Market Revenues & Volume, By Peripheral Artery Disease, 2021- 2031F |
6.2.4 Australia Plaque Modification Devices Market Revenues & Volume, By Neurovascular Disease, 2021- 2031F |
6.2.5 Australia Plaque Modification Devices Market Revenues & Volume, By Others, 2021- 2031F |
6.3 Australia Plaque Modification Devices Market, By End User |
6.3.1 Overview and Analysis |
6.3.2 Australia Plaque Modification Devices Market Revenues & Volume, By Hospitals, 2021- 2031F |
6.3.3 Australia Plaque Modification Devices Market Revenues & Volume, By Specialty Clinics, 2021- 2031F |
6.3.4 Australia Plaque Modification Devices Market Revenues & Volume, By Ambulatory Surgical Centers, 2021- 2031F |
7 Australia Plaque Modification Devices Market Import-Export Trade Statistics |
7.1 Australia Plaque Modification Devices Market Export to Major Countries |
7.2 Australia Plaque Modification Devices Market Imports from Major Countries |
8 Australia Plaque Modification Devices Market Key Performance Indicators |
9 Australia Plaque Modification Devices Market - Opportunity Assessment |
9.1 Australia Plaque Modification Devices Market Opportunity Assessment, By Product Type, 2021 & 2031F |
9.2 Australia Plaque Modification Devices Market Opportunity Assessment, By Application, 2021 & 2031F |
9.3 Australia Plaque Modification Devices Market Opportunity Assessment, By End User, 2021 & 2031F |
10 Australia Plaque Modification Devices Market - Competitive Landscape |
10.1 Australia Plaque Modification Devices Market Revenue Share, By Companies, 2024 |
10.2 Australia Plaque Modification Devices Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |